Prostate Cancer Drug Zytiga May Extend Life

The newly approved prostate cancer pill Zytiga (abiraterone acetate) may extend life by up to four months among men with spreading cancer who have already been treated with chemotherapy, a study shows.

Click here to read the full story.

Post a Comment
 

 
Comments
No comments yet!
Inergize Digital This site is hosted and managed by Inergize Digital.
   

WTVQ.com supports children's privacy rights. All persons under the age of 13 MUST have parental permission to use this website and direct parental supervision is strongly recommended.